Cellular interactions of 5-fluorouracil and the camptothecin analogue CPT-11 (irinotecan) in a human colorectal carcinoma cell line
- 30 March 1998
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 55 (5) , 667-676
- https://doi.org/10.1016/s0006-2952(97)00541-8
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- CPT-11 (Irinotecan) and 5-Fluorouracil: a Promising Combination for Therapy of Colorectal CancerEuropean Journal Of Cancer, 1996
- CPT-11 (Irinotecan) in the treatment of colorectal cancerEuropean Journal Of Cancer, 1995
- A role for dihydropyrimidine dehydrogenase and thymidylate synthase in tumour sensitivity to fluorouracilEuropean Journal Of Cancer, 1994
- Effects of CPT‐11 in combination with other anti‐cancer agents in cultureInternational Journal of Cancer, 1992
- New Colorimetric Cytotoxicity Assay for Anticancer-Drug ScreeningJNCI Journal of the National Cancer Institute, 1990
- Do antimetabolites interfere with the glycosylation of cellular glycoconjugates?European Journal of Cancer and Clinical Oncology, 1990
- Clinical Pharmacology of 5-FluorouracilClinical Pharmacokinetics, 1989
- DNA topoisomerases and DNA repairBioEssays, 1988
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976
- Plant Antitumor Agents. I. The Isolation and Structure of Camptothecin, a Novel Alkaloidal Leukemia and Tumor Inhibitor from Camptotheca acuminata1,2Journal of the American Chemical Society, 1966